These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 2509396

  • 1. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
    Robison WG, Nagata M, Tillis TN, Laver N, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
    [Abstract] [Full Text] [Related]

  • 2. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG, Nagata M, Laver N, Hohman TC, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [Abstract] [Full Text] [Related]

  • 3. Galactose-induced retinal microangiopathy in rats.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [Abstract] [Full Text] [Related]

  • 4. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
    Robison WG, Kador PF, Akagi Y, Kinoshita JH, Gonzalez R, Dvornik D.
    Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
    [Abstract] [Full Text] [Related]

  • 5. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
    Nagata M, Robison WG.
    Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
    [Abstract] [Full Text] [Related]

  • 6. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
    Robison WG, Tillis TN, Laver N, Kinoshita JH.
    Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
    [Abstract] [Full Text] [Related]

  • 7. Aldose reductase and retinal capillary basement membrane thickening.
    Robison WG, Nagata M, Kinoshita JH.
    Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
    [Abstract] [Full Text] [Related]

  • 8. Reduction of basement membrane thickening in diabetic cat retina by sulindac.
    Mansour SZ, Hatchell DL, Chandler D, Saloupis P, Hatchell MC.
    Invest Ophthalmol Vis Sci; 1990 Mar 01; 31(3):457-63. PubMed ID: 2318584
    [Abstract] [Full Text] [Related]

  • 9. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells.
    Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tsai JY, Kador PF.
    Invest Ophthalmol Vis Sci; 1999 Mar 01; 40(3):697-704. PubMed ID: 10067973
    [Abstract] [Full Text] [Related]

  • 10. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K, Matsubara H, Harada T, Mizuno K, Suzuki M, Hotta N, Kakuta H, Sakamoto N.
    Jpn J Ophthalmol; 1985 Mar 01; 29(1):99-109. PubMed ID: 3159927
    [Abstract] [Full Text] [Related]

  • 11. The polyol pathway in retinal microangiopathy.
    Robison WG, Kinoshita JH, Kador PF.
    Drugs; 1986 Mar 01; 32 Suppl 2():19-22. PubMed ID: 3098542
    [Abstract] [Full Text] [Related]

  • 12. Pericyte coverage of retinal and cerebral capillaries.
    Frank RN, Turczyn TJ, Das A.
    Invest Ophthalmol Vis Sci; 1990 Jun 01; 31(6):999-1007. PubMed ID: 2354923
    [Abstract] [Full Text] [Related]

  • 13. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG, Laver NM, Jacot JL, Glover JP.
    Invest Ophthalmol Vis Sci; 1995 Nov 01; 36(12):2368-80. PubMed ID: 7591626
    [Abstract] [Full Text] [Related]

  • 14. Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.
    Frank RN, Keirn RJ, Kennedy A, Frank KW.
    Invest Ophthalmol Vis Sci; 1983 Nov 01; 24(11):1519-24. PubMed ID: 6642931
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
    Robison WG, Laver NM, Jacot JL, Chandler ML, York BM, Glover JP.
    Invest Ophthalmol Vis Sci; 1997 May 01; 38(6):1066-73. PubMed ID: 9152226
    [Abstract] [Full Text] [Related]

  • 16. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A, Frank RN, Zhang NL, Samadani E.
    Exp Eye Res; 1990 Mar 01; 50(3):269-80. PubMed ID: 2108050
    [Abstract] [Full Text] [Related]

  • 17. Aldose reductase activity and basement membrane thickening.
    Frank RN.
    Metabolism; 1986 Apr 01; 35(4 Suppl 1):35-40. PubMed ID: 3083207
    [Abstract] [Full Text] [Related]

  • 18. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF, Takahashi Y, Akagi Y, Neuenschwander H, Greentree W, Lackner P, Blessing K, Wyman M.
    Invest Ophthalmol Vis Sci; 2002 Jun 01; 43(6):1916-21. PubMed ID: 12036999
    [Abstract] [Full Text] [Related]

  • 19. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA.
    Exp Eye Res; 1993 Dec 01; 57(6):723-35. PubMed ID: 8150024
    [Abstract] [Full Text] [Related]

  • 20. Absence of degenerative changes in retinal and uveal capillary pericytes in diabetic rats.
    Tilton RG, LaRose LS, Kilo C, Williamson JR.
    Invest Ophthalmol Vis Sci; 1986 May 01; 27(5):716-21. PubMed ID: 3700020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.